Rapid Fire: Development Strategy for Novel Targeted Therapeutic Delivery

Rapid Fire Moderator(s)

• 

  Wei Wei, PhD (she/her/hers)

  Senior Scientist
  Boehringer Ingelheim
  Danbury, Connecticut

Presentations:

• 2:30 PM – 2:45 PM PT

  Advanced ADA-Domain-Characterization for T-cell-Engager-Drugs to Understand Exposure and Activity Impact
  

  Rapid Fire Speaker: Gregor P. Lotz, PhD (he/him/his) – Roche Diagnostics GmbH
• 2:45 PM – 3:00 PM PT

  Spectral Unmixing Impact Comparison Across Immunophenotyping Panels and Matrices
  

  Rapid Fire Speaker: Nassouh Mourabet, MS (he/him/his) – KCAS Bio
• 3:00 PM – 3:15 PM PT

  Identifying Inflammatory Biomarkers in Small-Cell Lung Cancer Using Olink Assays
  

  Rapid Fire Speaker: Jeff Chen, PhD – AstraZeneca
• 3:15 PM – 3:30 PM PT

  High-Dimensional Immunophenotyping Panel to Characterize Chimeric-Antigen-Receptor T Cells in Clinical-Trials
  

  Rapid Fire Speaker: Rohini Emani, PhD (she/her/hers) – Astrazeneca